PRAX Praxis Precision Medicines, Inc.

Fundamentals / CIK 0001689548 / USD

Praxis Precision Medicines, Inc. reported $0 in revenue and a net loss of $359.4M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PRAX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$40.45M$20.23M$0-$284.3MFY 2019 Net Income: -$35.51M2019FY 2020 Net Income: -$61.82M2020FY 2021 Net Income: -$167.1M2021FY 2022 Revenue: $0FY 2022 Net Income: -$214.0M2022FY 2023 Revenue: $2.45MFY 2023 Net Income: -$123.3M2023FY 2024 Revenue: $8.55MFY 2024 Net Income: -$182.8M2024FY 2025 Revenue: $0FY 2025 Net Income: -$303.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $8.55M $2.45M $0 -- -- --
Research & Development $267.1M $152.4M $86.77M $155.0M $120.3M $44.98M $29.56M
Total Operating Expenses $326.2M $208.7M $128.8M $215.0M $167.3M $61.97M $35.79M
Operating Income -$326.2M -$200.2M -$126.4M -$215.0M -$167.3M -$61.97M -$35.79M
EBITDA -$326.1M -$199.8M -$125.9M -$214.6M -$167.2M -$61.92M -$35.75M
Interest Income -- -- -- $957K $271K $140K $193K
Income Before Tax -$302.8M -$182.7M -$123.0M -- -$167.1M -$61.83M -$35.60M
Income Tax Expense $471K -- -- -- $0 -$8.0K -$84K
Net Income -$303.3M -$182.8M -$123.3M -$214.0M -$167.1M -$61.82M -$35.51M
Basic EPS -$13.48 -$10.21 -$18.69 -$69.65 -$59.10 -$117.90 -$399.00
Diluted EPS -$13.48 -$10.21 -$18.69 -$69.65 -$59.10 -$117.90 -$399.00
Basic Shares Outstanding 22.5M 17.9M 6.6M 3.1M 2.8M 596.7K 102.0K
Diluted Shares Outstanding 22.5M 17.9M 6.6M 3.1M 2.8M 596.7K 102.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $0 $0 $7.46M
Research & Development $64.20M $69.42M $77.99M $77.51M $65.80M $63.01M $60.81M $56.29M
Total Operating Expenses $106.9M $96.90M $105.9M $97.04M $78.36M $76.07M $74.73M $71.42M
Operating Income -$106.9M -$96.90M -$105.9M -$97.04M -$78.36M -$76.07M -$74.73M -$63.96M
EBITDA -$106.9M -$96.87M -$105.8M -$97.02M -$78.34M -$76.02M -$74.68M -$63.91M
Net Income -$94.23M -$83.72M -$92.56M -$88.91M -$73.93M -$71.13M -$69.30M -$58.68M
Basic EPS -$3.23 -$2.87 -$3.20 -- -$3.36 -$3.31 -$3.29 --
Diluted EPS -$3.23 -$2.87 -$3.20 -- -$3.36 -$3.31 -$3.29 --
Basic Shares Outstanding 29.2M 29.1M 28.9M -- 22.0M 21.5M 21.1M --
Diluted Shares Outstanding 29.2M 29.1M 28.9M -- 22.0M 21.5M 21.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $357.3M $215.4M $81.30M $61.62M $138.7M $296.6M $44.81M
Short-Term Investments $242.0M $177.2M $0 $38.87M $105.7M -- --
Cash & Short-Term Investments $926.1M $469.5M $0 $100.5M $275.9M $296.6M $44.81M
Total Current Assets $610.9M $404.4M $84.88M $110.8M $287.4M $302.3M $45.50M
Property, Plant & Equipment, Net $147K $230K $588K $971K $1.21M $82K $128K
Intangible Assets $0 -- -- -- -- -- --
Long-Term Investments $326.8M $76.96M $0 -- $31.53M -- --
Other Non-Current Assets $0 $416K $416K $416K $472K $15K $620K
Total Non-Current Assets $327.0M $78.74M $3.07M $4.29M $5.34M $851K $2.20M
Total Assets $937.9M $483.1M $87.95M $115.1M $292.7M $303.2M $47.69M
Accounts Payable $24.63M $12.53M $5.82M $14.67M $10.78M $4.09M $2.67M
Deferred Revenue (Current) -- $0 $1.39M $2.82M $0 -- --
Total Current Liabilities $59.77M $37.55M $15.75M $34.34M $38.43M $15.72M $6.82M
Deferred Revenue (Non-Current) -- $0 $1.16M $2.18M $0 -- --
Total Non-Current Liabilities $0 $110K $2.53M $4.68M $3.50M $0 $763K
Total Liabilities $59.77M $37.66M $18.28M $39.02M $41.94M $15.72M $7.58M
Total Debt (incl. Leases) $110K $1.37M $2.50M $3.50M $4.31M $763K $1.46M
Common Stock $15K $14K $13K $5.0K $5.0K $4.0K $1.0K
Retained Earnings -$1.14B -$836.7M -$653.9M -$530.6M -$316.6M -$149.6M -$81.01M
Accumulated Other Comp. Income $563K $654K $0 -$173K -$176K $0 --
Total Stockholders' Equity $878.1M $445.4M $69.67M $76.11M $250.8M $287.5M -$81.01M
Total Equity $878.1M $445.4M $69.67M $76.11M $250.8M $287.5M -$81.01M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $361.9M $474.8M $536.3M $357.3M $149.5M $157.4M $165.6M $215.4M
Short-Term Investments $383.5M $283.8M $250.5M $242.0M $117.6M $143.9M $162.4M $177.2M
Cash & Short-Term Investments $1.30B $1.40B $1.40B $926.1M $389.2M $446.6M $472.0M $469.5M
Total Current Assets $762.8M $771.9M $797.8M $610.9M $273.8M $306.6M $333.6M $404.4M
Property, Plant & Equipment, Net $1.90M $492K $170K $147K $174K $258K $247K $230K
Intangible Assets -- $773K -- $0 -- -- -- --
Long-Term Investments $540.7M $615.3M $660.9M $326.8M $122.0M $145.4M $144.0M $76.96M
Other Non-Current Assets $6.00M $643K -- $0 $0 $0 $0 $416K
Total Non-Current Assets $549.3M $618.2M $662.4M $327.0M $122.5M $146.3M $145.2M $78.74M
Total Assets $1.31B $1.39B $1.46B $937.9M $396.4M $452.8M $478.7M $483.1M
Accounts Payable $15.02M $23.39M $31.16M $24.63M $30.82M $28.83M $22.91M $12.53M
Deferred Revenue (Current) -- -- -- -- -- -- -- $0
Total Current Liabilities $52.50M $49.06M $50.24M $59.77M $52.88M $48.61M $39.52M $37.55M
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $110K
Total Liabilities $52.50M $49.06M $50.24M $59.77M $52.88M $48.61M $39.52M $37.66M
Total Debt (incl. Leases) $732K $1.09M $1.44M $110K $436K $755K $1.07M $1.37M
Common Stock $15K $15K $15K $15K $14K $14K $14K $14K
Retained Earnings -$1.41B -$1.32B -$1.23B -$1.14B -$1.05B -$977.2M -$906.0M -$836.7M
Accumulated Other Comp. Income -$5.73M -$2.67M -$1.59M $563K $500K $395K $659K $654K
Total Stockholders' Equity $1.26B $1.34B $1.41B $878.1M $343.5M $404.2M $439.2M $445.4M
Total Equity $1.26B $1.34B $1.41B $878.1M $343.5M $404.2M $439.2M $445.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$303.3M -$182.8M -$123.3M -$214.0M -$167.1M -$61.82M -$35.51M
Depreciation & Amortization $140K $358K $432K $419K $182K $50K $37K
Stock-Based Compensation $33.94M $41.36M $24.86M $28.59M $22.69M $5.21M $668K
Change in Payables $12.10M $6.71M -$8.86M $3.89M $7.27M $960K -$837K
Operating Cash Flow -$249.1M -$131.8M -$111.1M -$185.0M -$124.6M -$52.62M -$33.42M
Capital Expenditure -$56K $0 -$50K -$444K -$1.05M $0 -$103K
Free Cash Flow -$249.1M -$131.8M -$111.2M -$185.5M -$125.6M -$52.62M -$33.52M
Purchases of Investments -$623.8M -$371.5M $0 -$83.02M -$164.2M $0 --
Investing Cash Flow -$311.1M -$248.5M $38.95M $96.89M -$140.5M $0 -$103K
Common Stock Issued $1.80B $1.10B $617.5M $0 $98.41M $0 --
Financing Cash Flow $702.2M $514.3M $91.87M $10.46M $107.6M $304.4M $60.39M
Net Change in Cash $142.0M $134.1M $19.68M -$77.69M -$157.5M $251.8M $26.86M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$94.23M -$83.72M -$92.56M -$88.91M -$73.93M -$71.13M -$69.30M -$58.68M
Depreciation & Amortization $33K $33K $39K $28K $19K $46K $47K $47K
Stock-Based Compensation $14.89M $11.31M $17.11M $9.94M $7.45M $7.77M $8.79M $8.57M
Change in Payables -$8.26M -$7.88M $6.53M -$6.19M $1.99M $5.92M $10.38M -$2.48M
Operating Cash Flow -$81.74M -$77.54M -$86.15M -$76.33M -$65.06M -$54.68M -$53.01M -$56.12M
Capital Expenditure -$1.55M -$245K -$62K $0 $0 -$56K $0 --
Free Cash Flow -$83.29M -$77.79M -$86.21M -$76.33M -$65.06M -$54.73M -$53.01M --
Purchases of Investments -$156.7M -$77.27M -$486.8M -$390.3M -$75.13M -$41.35M -$117.1M -$69.42M
Investing Cash Flow -$32.10M $10.98M -$344.3M -$328.4M $50.41M $17.89M -$51.06M -$10.92M
Common Stock Issued $0 $0 $2.40B $600.0M $0 $0 $1.20B $100.0M
Financing Cash Flow $929K $4.57M $609.4M $612.5M $6.76M $28.63M $54.27M $113.8M
Net Change in Cash -$112.9M -$61.99M $179.0M $207.8M -$7.89M -$8.15M -$49.80M $46.73M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -2340.3% -5164.4% -- -- -- --
Net Profit Margin -- -2137.5% -5037.9% -- -- -- --
Return on Equity (ROE) -34.5% -41.0% -176.9% -281.2% -66.6% -21.5% --
Return on Assets (ROA) -32.3% -37.8% -140.2% -185.9% -57.1% -20.4% -74.5%
Current Ratio 10.22x 10.77x 5.39x 3.23x 7.48x 19.23x 6.67x
Quick Ratio 15.49x 12.50x 0.00x 2.93x 7.18x 18.87x 6.57x
Debt to Equity 0.00x 0.00x 0.04x 0.05x 0.02x 0.00x --
Revenue Growth (YoY) -100.0% +249.5% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -3927.5% -3497.6% -2868.8% -2340.3%
Net Profit Margin -- -- -- -- -3658.5% -3232.6% -2617.1% -2137.5%
Return on Equity (ROE) -28.5% -25.3% -23.2% -34.5% -79.5% -62.1% -48.4% -41.0%
Return on Assets (ROA) -27.4% -24.4% -22.4% -32.3% -68.9% -55.4% -44.4% -37.8%
Current Ratio 14.53x 15.73x 15.88x 10.22x 5.18x 6.31x 8.44x 10.77x
Quick Ratio 24.76x 28.54x 27.87x 15.49x 7.36x 9.19x 11.94x 12.50x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x
Revenue Growth (YoY) -- -- -- -100.0% -100.0% -100.0% -100.0% +1349.1%
Source: SEC EDGAR CompanyFacts (CIK 0001689548) · from September 30, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:10 UTC · Open in terminal